These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

892 related items for PubMed ID: 6439161

  • 1. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 2. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P, Leclercq JF, Assayag P.
    Am J Cardiol; 1984 Nov 14; 54(9):60D-66D. PubMed ID: 6208770
    [Abstract] [Full Text] [Related]

  • 3. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct 14; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 4. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G.
    Monatsschr Kinderheilkd; 1985 Mar 14; 133(3):154-7. PubMed ID: 4010670
    [Abstract] [Full Text] [Related]

  • 5. [Oral propafenone in refractory arrhythmia. Apropos of 68 patients].
    Haissaguerre M, Wicker F, Goldrach S, Vrancea F, Regaudie JJ, Le Metayer P, Warin JF, Blanchot P.
    Ann Cardiol Angeiol (Paris); 1986 Mar 14; 35(3):173-9. PubMed ID: 3707020
    [Abstract] [Full Text] [Related]

  • 6. Worsening of arrhythmias during pharmacological treatment.
    Furlanello F, Gramegna L, Dal Forno P, Vergara G, Bettini R, Inama G, Disertori M.
    G Ital Cardiol; 1984 Oct 14; 14(10):798-803. PubMed ID: 6440827
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F, Palmieri M, del Corso P, Lombardi G, Bracchetti D.
    Arzneimittelforschung; 1982 Oct 14; 32(5):547-50. PubMed ID: 7201833
    [Abstract] [Full Text] [Related]

  • 8. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases].
    Lucet V, Do Ngoc D, Fidelle J, Sidi D, Batisse A, Loth P, Vrancea F, Villain E, Coumel P.
    Arch Mal Coeur Vaiss; 1987 Aug 14; 80(9):1385-93. PubMed ID: 3122689
    [Abstract] [Full Text] [Related]

  • 9. [Clinical study of a new anti-arrhythmic drug: propafenon. Short and long-term results].
    Ruipércz Abizanda JA, Campos Peris JV, García García J, Jaen Armand E, Ruiz Ros JA, Salas Nieto J, Rodríguez Ruiz P, Marco Quiles J, Martínez Jérez M, Pico Aracil F.
    Arch Inst Cardiol Mex; 1981 Aug 14; 51(4):371-6. PubMed ID: 7337481
    [Abstract] [Full Text] [Related]

  • 10. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr 14; 13(70):64-9. PubMed ID: 15148984
    [Abstract] [Full Text] [Related]

  • 11. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF, Georgiopoulos G, Halkidis H, Attuel P, Maisonblanche P, Coumel P.
    Arch Mal Coeur Vaiss; 1981 Dec 14; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract] [Full Text] [Related]

  • 12. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW, Rotem CE, Boroomand-Rashti K, Bar-Shlomo B.
    Can Med Assoc J; 1984 Sep 15; 131(6):601-3. PubMed ID: 6478345
    [Abstract] [Full Text] [Related]

  • 13. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May 15; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 14. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation].
    Breithardt G, Haerten K, Seipel L.
    Z Kardiol; 1976 Aug 15; 65(8):713-23. PubMed ID: 61664
    [Abstract] [Full Text] [Related]

  • 15. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF, Coumel P.
    Arch Mal Coeur Vaiss; 1983 Oct 15; 76(10):1218-30. PubMed ID: 6418100
    [Abstract] [Full Text] [Related]

  • 16. [Propafenon therapy of arrhythmias in infancy and childhood (author's transl)].
    Weber H, Eigster G, Wesselhoeft H.
    Monatsschr Kinderheilkd; 1981 Jul 15; 129(7):410-3. PubMed ID: 6167855
    [Abstract] [Full Text] [Related]

  • 17. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A, Adragão P, Bonhorst D, Seabra-Gomes R.
    Rev Port Cardiol; 1990 Jan 15; 9(1):33-9. PubMed ID: 1691653
    [Abstract] [Full Text] [Related]

  • 18. [Oral propafenone in resistant auricular arrhythmia].
    Bounhoure JP, Sabot G, Cassagneau B, Calazel J, Dechandol AM.
    Ann Cardiol Angeiol (Paris); 1985 Jan 15; 34(7):485-8. PubMed ID: 4062207
    [Abstract] [Full Text] [Related]

  • 19. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H.
    Z Kardiol; 1988 Jul 15; 77(7):464-9. PubMed ID: 2463720
    [Abstract] [Full Text] [Related]

  • 20. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P.
    G Ital Cardiol; 1986 Apr 15; 16(4):328-32. PubMed ID: 2427383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.